As reported by The Information, insiders are saying that Chinese competition regulators haven’t even started their formal review of NVIDIA’s proposed acquisition, which can take up to six months and spans three phases. Furthermore, given the scope of NVIDIA’s deal, it may have to go through the process twice or even thrice.
What’s strange about this particular case is the lack of clarity around why Chinese regulators haven’t begun reviewing the case, given that NVIDIA’s and ARM’s filing is in. The Information speculated that one possible reason for the lack of immediate action on China’s end could be that Huawei and ZTE, two Chinese licensees of ARM, oppose the deal. The extent of their voiced opposition’s influence also remains unclear.
However, Huawei and ZTE aren’t the only companies not digging the deal. Qualcomm has also been a voice amongst the many companies that dislike NVIDIA’s current acquisition attempt.
Also, to add to the pile of complications, there’s the fact that ARM China is currently trying to kick out its CEO Allen Wu even though he refuses to leave, which has been the source of extended litigation stemming from the fact that Wu is, in essence, “both the plaintiff and the defendant,” as stated by The Information.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
College Sports Leaders in Intensive Talks to Settle NIL Antitrust Case Against NCAA
Apr 30, 2024 by
CPI
EU Investigates Facebook’s and Instagram’s Handling of Disinformation Ahead of Elections
Apr 30, 2024 by
CPI
Antitrust Lawsuit Targets Hotel Giants for Alleged Price Fixing with AI
Apr 30, 2024 by
CPI
ABA Seeks to Join FTC Lawsuit Against Amazon Over Antitrust Concerns
Apr 30, 2024 by
CPI
Google Agrees to Pay News Corp for AI-Related Content
Apr 30, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI